Since TGFβ1 signaling was found to be highly expressed in both experimental animal models and clinical PAH patients, therefore, deviant BMP signaling and epigenetic dysregulation promote cell proliferation, which dramatically increases the risk of PAH pathogenesis [18] (Figure 2B). This evidence concerns the gene TGFB1 and pulmonary arterial hypertension.